415 related articles for article (PubMed ID: 27332042)
1. Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
Oaks Z; Winans T; Caza T; Fernandez D; Liu Y; Landas SK; Banki K; Perl A
Arthritis Rheumatol; 2016 Nov; 68(11):2728-2739. PubMed ID: 27332042
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
[TBL] [Abstract][Full Text] [Related]
3. HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.
Caza TN; Fernandez DR; Talaber G; Oaks Z; Haas M; Madaio MP; Lai ZW; Miklossy G; Singh RR; Chudakov DM; Malorni W; Middleton F; Banki K; Perl A
Ann Rheum Dis; 2014 Oct; 73(10):1888-97. PubMed ID: 23897774
[TBL] [Abstract][Full Text] [Related]
4. Altered β
Mobarrez F; Gunnarsson I; Svenungsson E
J Thromb Haemost; 2017 Sep; 15(9):1799-1806. PubMed ID: 28667788
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
6. Differential oxidative modification of proteins in MRL+/+ and MRL/lpr mice: Increased formation of lipid peroxidation-derived aldehyde-protein adducts may contribute to accelerated onset of autoimmune response.
Wang G; Li H; Firoze Khan M
Free Radic Res; 2012 Dec; 46(12):1472-81. PubMed ID: 22950782
[TBL] [Abstract][Full Text] [Related]
7. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
Yang J; Li Q; Yang X; Li M
Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
[TBL] [Abstract][Full Text] [Related]
11. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.
Knight JS; Subramanian V; O'Dell AA; Yalavarthi S; Zhao W; Smith CK; Hodgin JB; Thompson PR; Kaplan MJ
Ann Rheum Dis; 2015 Dec; 74(12):2199-206. PubMed ID: 25104775
[TBL] [Abstract][Full Text] [Related]
12. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Gut Microbiome Contributes to Intestinal Oxidative Stress, Barrier Dysfunction, Inflammation and Systemic Autoimmune Responses in MRL/lpr Mice.
Wang H; Wang G; Banerjee N; Liang Y; Du X; Boor PJ; Hoffman KL; Khan MF
Front Immunol; 2021; 12():651191. PubMed ID: 33912174
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus onset in lupus-prone B6.MRL/lpr mice Is influenced by weight gain and Is preceded by an increase in neutrophil oxidative burst activity.
Toller-Kawahisa JE; Canicoba NC; Venancio VP; Kawahisa R; Antunes LM; Cunha TM; Marzocchi-Machado CM
Free Radic Biol Med; 2015 Sep; 86():362-73. PubMed ID: 26117329
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
[TBL] [Abstract][Full Text] [Related]
16. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
[TBL] [Abstract][Full Text] [Related]
18. Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-
Fortner KA; Blanco LP; Buskiewicz I; Huang N; Gibson PC; Cook DL; Pedersen HL; Yuen PST; Murphy MP; Perl A; Kaplan MJ; Budd RC
Lupus Sci Med; 2020 Apr; 7(1):. PubMed ID: 32343673
[TBL] [Abstract][Full Text] [Related]
19. Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus.
Kato H; Perl A
Arthritis Rheumatol; 2018 Mar; 70(3):427-438. PubMed ID: 29161463
[TBL] [Abstract][Full Text] [Related]
20. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
